MTSEA effects on muscle mutants expressed in Xenopus oocytes
Muscle mutant | Before MTSEA | After MTSEA | ||
Imaxa | EC50 | Imaxa | EC50 | |
µM | µM | |||
α1β1γδL121C (n = 5) | 1.30 ± 0.05 | 12.7 ± 1.5 | 1.41 ± 0.03 | 111 ± 8 |
α1β1εL119Cδ (n = 3) | 2.72 ± 0.08 | 48 ± 4 | 2.40 ± 0.02 | 126 ± 4 |
α1β1εδL121C (n = 8) | 2.56 ± 0.01 | 39.1 ± 0.4 | 1.84 ± 0.04 | 145 ± 9 |
α1β1γδ wild-type (n = 5) | 1.15 ± 0.03 | 4.52 ± 0.39 | 1.35 ± 0.05 | 3.24 ± 0.41 |
α1β1εδ wild-type (n = 7) | 1.28 ± 0.003 | 16.1 ± 0.10 | 1.53 ± 0.004 | 22.0 ± 0.11 |
Muscle mutant | Before MTSEA | After MTSEA | ||
Imaxa | EC50 | Imaxa | EC50 | |
µM | µM | |||
α1β1γδL121C (n = 5) | 1.30 ± 0.05 | 12.7 ± 1.5 | 1.41 ± 0.03 | 111 ± 8 |
α1β1εL119Cδ (n = 3) | 2.72 ± 0.08 | 48 ± 4 | 2.40 ± 0.02 | 126 ± 4 |
α1β1εδL121C (n = 8) | 2.56 ± 0.01 | 39.1 ± 0.4 | 1.84 ± 0.04 | 145 ± 9 |
α1β1γδ wild-type (n = 5) | 1.15 ± 0.03 | 4.52 ± 0.39 | 1.35 ± 0.05 | 3.24 ± 0.41 |
α1β1εδ wild-type (n = 7) | 1.28 ± 0.003 | 16.1 ± 0.10 | 1.53 ± 0.004 | 22.0 ± 0.11 |
Measured relative to average 30-µM ACh control before MTSEA treatment.